Alpha Tau Medical (DRTS) Accounts Payables (2020 - 2026)

Alpha Tau Medical has disclosed Accounts Payables across 7 years of filings, most recently posting $3.7 million for Q1 2026.

• Accounts Payables for Q1 2026 came in at $3.7 million, up 44.28% year-over-year; the trailing twelve-month figure through Mar 2026 was $3.7 million (up 44.28% YoY), and the FY2025 annual result was $3.9 million, up 9.54% from the prior year.
• Accounts Payables came in at $3.7 million for Q1 2026 at Alpha Tau Medical, down from $3.9 million in the prior quarter.
• In the past five years, Accounts Payables ranged from a high of $3.9 million in Q4 2025 to a low of $1.2 million in Q2 2022.
• The 5-year median for Accounts Payables is $2.5 million (2024), against an average of $2.5 million.
• Peak annual rise in Accounts Payables reached 80.32% in 2023, while the deepest fall reached 45.99% in 2023.
• Alpha Tau Medical's Accounts Payables stood at $1.4 million in 2022, then surged by 80.32% to $2.6 million in 2023, then surged by 37.61% to $3.5 million in 2024, then gained by 9.54% to $3.9 million in 2025, then decreased by 3.88% to $3.7 million in 2026.
• The last three Accounts Payables figures came in at $3.7 million (Q1 2026), $3.9 million (Q4 2025), and $3.1 million (Q3 2025), per Business Quant data.